A Randomized, Placebo-Controlled Phase 2 Study of Ganitumab or Conatumumab in Combination With FOLFIRI for Second-Line Treatment of Mutant KRAS Metastatic Colorectal Cancer
Academic Article
Publication Date:
2013
Short description:
A Randomized, Placebo-Controlled Phase 2 Study of Ganitumab or Conatumumab in Combination With FOLFIRI for Second-Line Treatment of Mutant KRAS Metastatic Colorectal Cancer / Cohn, A.l., Tabernero, J., Maurel, J., Nowara, E., Sastre, J., Chuah, B., Kopp, M.v., Sakaeva, D.d., Mitchell, E.p., Dubey, S., Suzuki, S., Hei, Y., Galimi, F., Mccaffery, I., Pan, Y., Loberg, R., Cottrell, S., Choo, S.p.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 24:7(2013), pp. 1777-1785. [10.1093/annonc/mdt057]
Iris type:
1.1 Articolo in rivista
List of contributors:
Cohn, Al; Tabernero, J; Maurel, J; Nowara, E; Sastre, J; Chuah, Bys; Kopp, Mv; Sakaeva, Dd; Mitchell, Ep; Dubey, S; Suzuki, S; Hei, Y; Galimi, Francesco; Mccaffery, I; Pan, Y; Loberg, R; Cottrell, S; Choo, Sp
Published in: